RxDoctor Payments Data

Serguei Melnitchouk, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Boston, MANPI 1437176898

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (31.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 85.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $17,172 and has fallen 83.0% since, to $2,922 in 2025.

$37,050in general payments, 2019–2025

Across 54 payments — averaging $686.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$32K
  • Intuitive Surgical$4K
  • Edwards Lifesciences$1K
  • Arthrex$214
  • Abbott$171
$365,736in research payments, 2019–2025

Across 77 payments — averaging $4749.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$363K
  • Edwards Lifesciences$3K

What the payments were for

  • Consulting fees$9,00024%
  • Speaking & faculty fees$11,70032%
  • Travel & lodging$11,60031%
  • Food & beverage$1,7505%
  • Education$3,0008%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)43$31,692
Intuitive Surgical5$3,735
Edwards Lifesciences2$1,238
Arthrex2$214
Abbott2$171

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,050 in reported general payments places this provider in the 85th percentile of 171 thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts

Medicare billing

Part B allowed, 2024
$259,602
Medicare patients
111
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →